Evidence-based approach for surgery during COVID-19: Review of the literature and social media

Vajsbaher, Tina; Curtis, Nathan; Slim, Naim; Mayol, Julio; Francis, Nader

doi:10.1002/bjs.11851

Cited by 2 publications

(2 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…8 However, the rapid global spread of COVID-19 presents an unprecedented crisis for the surgical community. 9 During the pandemic, hospitals have reduced the number of elective surgery to ensure patient safety and support a more comprehensive response. 10 In cancer patients, a delay in surgery may increase the risk of metastatic lesions.…”

Section: Introductionmentioning

confidence: 99%

The safety of digestive tract cancer surgery during COVID-19: A living systematic review and meta-analysis

Wang

Yao

et al. 2023

Asian Journal of Surgery

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

The safety of digestive tract cancer surgery during COVID-19: A living systematic review and meta-analysis

Wang

Yao

et al. 2023

Asian Journal of Surgery

View full text Add to dashboard Cite

“…[ 6 ] Besides, the rapid global spread of COVID-19 presents an unprecedented crisis for esophagectomy. [ 7 ] Recent reports suggest that patients with cancer might have a higher risk of COVID-19 than individuals without cancer and patients with cancer had poorer outcomes from COVID-19. [ 8 ] In particular, for patients with EC, additional precautions have been taken, as surgery for EC alone has higher morbidity and mortality rates compared to that for other oncological surgeries.…”

Section: Introductionmentioning

confidence: 99%

The safety of esophageal cancer surgery during COVID-19

Wang

Yao

et al. 2022

Medicine

View full text Add to dashboard Cite

Background: The ongoing coronavirus disease 2019 (COVID-19) pandemic has drastically challenged the safety of on esophageal cancer (EC) surgery during COVID-19. The study aimed to evaluate the safety of EC surgery during the COVID-19 pandemic. Methods: This systematic review was performed in accordance with the PRISMA-P 2015 guidelines and registered in PROSPERO (registration number: CRD42022335164). A systematic search of PubMed, Embase, Cochrane Library, Web of Science, Medline, Chinese National Knowledge Infrastructure database, Chinese Scientific Journal database, and Wan Fang database was conducted to identify potentially relevant publications from January 2020 to May 2022. All data were independently extracted by two researchers. We will apply a fixed-effect model or random effect model basis on the heterogeneity test and employ with RevMan 5.4.1 software for data synthesis. The dichotomous surgical outcomes used risk ratios or risk differences, and for continuous surgical outcomes, mean differences (MD) or standardized MD, both with 95% confidence intervals were used. The primary outcomes were postoperative complications, anastomotic leaks, and mortality. The secondary outcomes were total hospital stay, postoperative stay, preoperative waiting, operation time, blood loss, transfusion, postoperative intensive care unit (ICU) stay, number of patients needing ICU stay, and 30-day readmission. Results: This study will comprehensively summarize the high-quality trials to determine the safety of EC surgery during COVID-19. Conclusion: Our systematic review and meta-analysis will present evidence for the safety of EC surgery during COVID-19.

show abstract

Evidence-based approach for surgery during COVID-19: Review of the literature and social media

Cited by 2 publications

References 5 publications

The safety of digestive tract cancer surgery during COVID-19: A living systematic review and meta-analysis

The safety of digestive tract cancer surgery during COVID-19: A living systematic review and meta-analysis

The safety of esophageal cancer surgery during COVID-19

Contact Info

Product

Resources

About